DelveInsight's 'Systemic Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of pipeline ...

After the unexpected success of their PHOENYCS GO study for dapirolizumab pegol in lupus earlier this fall, Biogen and UCB ...

A phase 3 trial of Biogen (NASDAQ:BIIB) and UCB's (OTCPK:UCBJF)(OTCPK:UCBJY) dapirolizumab pegol for systemic lupus ...

The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...

In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to ...

Fate said it is also enrolling a second treatment arm under the Phase 1 Autoimmunity study to evaluate a single dose of FT819 ...

Natural treatments for lupus are typically used as complementary therapies alongside conventional treatments. Learn more ...

(Getty Images) Lupus (more properly known as Systemic Lupus Erythematosus) is an autoimmune disease. "That means that, the ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

The 1.5 million Americans estimated to have the autoimmune disease lupus already have plenty to manage—what with the pain, ...

Fate Therapeutics (FATE) presented initial clinical and translational data from the first patient treated in its FT819 Phase 1 Autoimmunity study for moderate-to-severe systemic lupus erythematosus – ...

A groundbreaking trial found that Iberdomide, a cereblon modulator, can be added as a background medication in subacute and ...